FIELD: medicine.
SUBSTANCE: invention relates to medicine, namely to obstetrics and gynecology, oncology and can be used to treat kraurosis vulvae in women in the menopausal and postmenopausal period. For pathogenetic treatment, use the adipose tissue obtained from the hypogastric region of the patient after infiltration of subcutaneous fat in this area with Klein solution. It is decanted from the infiltration solution and processed through an emulsifier. Perform submucosal administration of emulsified adipose tissue in a volume of 10 to 20 ml in the affected area by linear retrograde technique with a uniform distribution of it in the lesion.
EFFECT: improvement of microcirculation in the affected areas of the vulva skin and mucosa of small and large labia in the focus of kraurosis due to the involvement of endothelial cells and stimulation of angiogenesis, as well as due to the suppression of the inflammatory reaction due to the entry into the focus of the prostaglandin E2 immunomodulating factor.
1 cl, 1 tbl, 1 ex
Title | Year | Author | Number |
---|---|---|---|
METHOD FOR THE TREATMENT OF LICHEN SCLEROSUS OF THE VULVA IN WOMEN | 2021 |
|
RU2755805C1 |
METHOD OF TREATING PATIENTS WITH SCLEROTROPHIC VULVAR LUCHENE IN CONSERVATIVE THERAPY | 2018 |
|
RU2698089C1 |
METHOD FOR TREATING VULVA KRAUROSIS AND LEUKOPLAKIA IN WOMEN | 2016 |
|
RU2630599C1 |
METHOD OF DIAGNOSIS OF KRAUROSIS VULVAE IN PERIMENOPAUSAL AGE WOMEN | 2016 |
|
RU2663309C1 |
METHOD FOR TREATMENT OF KRAUROSIS VULVAE ASSOCIATED WITH PRESENCE OF HUMAN PAPILLOMAVIRUS | 2016 |
|
RU2612821C1 |
METHOD OF TREATING PATIENTS WITH CHRONIC DYSTROPHIC DISEASES OF VULVA AND UTERINE CERVIX | 2019 |
|
RU2738550C1 |
METHOD OF TREATING PATIENTS WITH LOCALISED SCLERODERMA | 2014 |
|
RU2564905C1 |
METHOD OF TREATING DYSTROPHIC DISEASES OF VULVA | 2011 |
|
RU2482893C2 |
METHOD FOR ATROPHIC VAGINITIS TREATMENT | 2017 |
|
RU2646453C1 |
METHOD OF DIAGNOSTIC VULVAR CANCER IN WOMEN | 2017 |
|
RU2679097C1 |
Authors
Dates
2018-07-25—Published
2016-07-11—Filed